Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

被引：1
|
作者：
Spahn, M. [1 ]
Kneitz, S. [2 ]
Scholz, C. -J. [2 ]
Stenger, N. [1 ]
Ruediger, T. [3 ]
Stroebel, P. [4 ]
Riedmiller, H. [5 ]
Kneitz, B. [5 ]
机构：
[1] Univ Hosp Wurzburg, Dept Urol & Pediat Urol, Wurzburg, Germany
[2] Univ Wurzburg, Microarray Core Unit, IZKF Interdisciplinary Ctr Clin Res, D-97070 Wurzburg, Germany
[3] Community Hosp Karlsruhe, Inst Pathol, Karlsruhe, Germany
[4] Univ Heidelberg, Inst Pathol, Univ Med Ctr Mannheim, D-6900 Heidelberg, Germany
[5] Univ Hosp Wurzburg, Dept Urol & Paediat Urol 1, Wurzburg, Germany
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(09)72211-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence
    Spahn, Martin
    Kneitz, Susanne
    Scholz, Claus-Juergen
    Stenger, Nico
    Ruediger, Thomas
    Stroebel, Philipp
    Riedmiller, Hubertus
    Kneitz, Burkhard
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (02) : 394 - 403
  • [2] DOWN-REGULATION OF MICRORNA-221 HALLMARKS PROSTATE CANCER METASTASIS AND IS A PREDICTOR OF CLINICAL RECURRENCE
    Spahn, M.
    Kneitz, S.
    Scholz, C. J.
    Stenger, N.
    Ruediger, T.
    Stroebel, P.
    Riedmiller, H.
    Kneitz, B.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 315 - 315
  • [3] MicroRNA-221 levels correlate with aggressive and clinically recurrent prostate cancers
    Gordanpour, Aida
    Stanimirovic, Aleksandra
    Nam, Robert
    Moreno, Carlos
    Leyland-Jones, Brian
    Sugar, Linda
    Seth, Arun
    [J]. CANCER RESEARCH, 2010, 70
  • [4] Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance
    Liu, K.
    Li, G.
    Fan, C.
    Diao, Y.
    Wu, B.
    Li, J.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (02) : 467 - 474
  • [5] DOWNREGULATION OF MIR-221 PROMOTES CANCER CELL PROLIFERATION, IS RELATED TO THE DEVELOPMENT OF AGGRESSIVE PROSTATE CANCER AND PREDICTS CLINICAL RECURRENCE
    Spahn, M.
    Kneitz, S.
    Scholz, C. J.
    Kaiogirou, C.
    Stroebel, P.
    Possner, M.
    Riedmiller, H.
    Kneitz, B.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 271 - 272
  • [6] Downregulation of miR-221 promotes cancer cell proliferation, is related to the development of aggressive prostate cancer and predicts clinical recurrence
    Spahn, M.
    Kneitz, S.
    Scholz, C. -J.
    Kalogirou, C.
    Stroebel, P.
    Riedmiller, H.
    Kneitz, B.
    [J]. ONKOLOGIE, 2010, 33 : 98 - 99
  • [7] MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK
    Qin, Jun
    Luo, Meng
    [J]. FEBS LETTERS, 2014, 588 (01) : 99 - 104
  • [8] Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells
    Wang, Lina
    Liu, Chunyan
    Li, Chaoyang
    Xue, Jing
    Zhao, Shihu
    Zhan, Panpan
    Lin, Yani
    Zhang, Pengju
    Jiang, Anli
    Chen, Weiwen
    [J]. GENE, 2015, 572 (02) : 252 - 258
  • [9] Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer
    Hong, Fanzhen
    Li, Yuyang
    Xu, Yongping
    Zhu, Lin
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (01) : 64 - 71
  • [10] The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
    Sun, Tong
    Wang, Qianben
    Balk, Steven
    Brown, Myles
    Lee, Gwo-Shu Mary
    Kantoff, Philip
    [J]. CANCER RESEARCH, 2009, 69 (08) : 3356 - 3363
12345